Q&A with Dr. Upton Allen
Q&A with Dr. Catalina Lopez‑Correa and Dr. Gary Van Domselaar
A new variant of the SARS-CoV-2 virus that spreads faster and more easily, is gaining a foothold in Canada—leaving researchers and public health officials asking if it will rapidly overtake the currently circulating strain.
When COVID-19 hit, Canada’s genomics research community stepped up immediately with strong responses for short-term containment and long-term management of the virus. But the pandemic is not the only area where smart investments in bio-innovation are making a difference.
The data generated by the virus sequencing initiative (VirusSeq) of the Canadian COVID-19 Genomics Network (CanCOGeN) will help track the transmission of SARS-CoV-2 (the virus that causes COVID-19), identify and monitor mutations that may influence disease severity or infectivity, and inform medical countermeasures.
The SARS-CoV-2 virus responsible for COVID-19 entered Quebec during the 2020 spring break period and may have been carried into the province by as few as 247 people, according to initial results from a study released on Sept. 21 by the Institut National de Santé Publique du Québec (INSPQ) and the McGill Genome Centre.
Guest blog by Paul Dufour, Adjunct Professor at University of Ottawa’s Institute for Science, Society and Policy and Principal of PaulicyWorks
Canada lost a remarkable science and innovation statesman on June 19.